Details of the NovAlix transaction - Advance (Details) - Drug discovery collaboration transaction with NovAliX € in Thousands |
12 Months Ended |
|---|---|
|
Dec. 31, 2023
EUR (€)
| |
| Ifrs Collaborative Arrangement And Arrangements Other Than Collaborative [Line Items] | |
| Loss on sale of fixed assets | € 12,506 |
| Result of transfer of retirement benefit liability | (3,022) |
| Result of transfer of right-of-use asset | 174 |
| Advance related to the NovAliX transaction | € 9,658 |